课题基金 / 基金详情

Mitochondrial calcium uptake in Alzheimer's disease

Mitochondrial calcium uptake in Alzheimer's disease
阿尔茨海默病中的线粒体钙摄取
批准号:
10055513
负责人:
Pooja Jadiya
金额:
$10.41万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-15 至 2022-07-31

项目摘要

项目成果

Pooja Jadiya的其他基金

相似基金

相关文献

中文摘要
翻译
摘要: 阿尔茨海默病(AD)的特征是记忆丧失并伴有神经细胞死亡和 代谢功能障碍。许多研究已经报道了神经细胞内钙离子的失调。 (iCa+)信号转导是AD发病机制中的早期事件。据认为,神经元的长期抬高 钙离子促进线粒体钙的过度摄取,但到目前为止还没有研究检查 线粒体钙摄取在疾病进展中的作用。由于mCa~(2+)流量是细胞内重要的调节因子 呼吸和细胞死亡,这两个都与AD的发病有关,我们假设mCa~(2+) 超负荷是AD病理的关键因素,并可能导致代谢缺陷和神经元死亡。 为了确定线粒体钙交换在阿尔茨海默病中的作用,我们建立了3xTg-AD突变小鼠,小鼠具有神经元特异性 线粒体钙单一转运体(MCU)的缺失,这是线粒体摄取钙所必需的。此外,我们还有 产生了一个功能获得突变的小鼠,表达了最近发现的线粒体钙单转运体 β亚基(MCUb)。MCUb最近被报道为mCa~(2+)摄取的负调节因子,我们已经 观察到其在AD中的表达发生了实质性变化。这些模型将允许因果实验 测试mCa~(2+)摄取是否推动AD的进展。将检查小鼠的记忆力改变,淀粉样变性, Tau-病理,氧化应激,突触和代谢功能。初步数据表明,线粒体钙摄取 过载会损害错误折叠的蛋白质和功能失调的线粒体的清除。因此,我们将 从机制上考察钙离子交换与自噬和有丝分裂途径之间的联系。 最好的情况是,拟议的研究将发现AD和相关线粒体的新治疗靶点 并提供培训和研究平台,促进PIS的自主研究事业。
英文摘要
Abstract: Alzheimer's disease (AD) is characterized by the loss of memory accompanied by neuronal cell death and metabolic dysfunction. Numerous studies have reported a dysregulation in neuronal intracellular calcium (iCa2+) signaling as an early event in AD pathogenesis. It is thought that a prolonged elevation in neuronal iCa2+ promotes excessive mitochondrial calcium (mCa2+) uptake, yet to date no study has examined the contribution of mCa2+ uptake to disease progression. Since mCa2+ flux is an important regulator of cellular respiration and cell death, both of which are involved in AD pathogenesis, we hypothesize that mCa2+ overload is a key contributor to AD pathology and may contribute to metabolic deficits and neuronal demise. To define the role of mCa2+ exchange in AD we have generated 3xTg-AD mutant mice with neuronal-specific deletion of Mitochondrial Calcium Uniporter (MCU), which is required for mCa2+ uptake. In addition, we have generated a gain-of-function mutant mouse expressing the recently identified mitochondrial calcium uniporter beta subunit (MCUb). MCUb was recently reported as a negative regulator of mCa2+ uptake and we have observed substantial changes in its expression in AD. These models will allow causative experimentation to test if mCa2+ uptake drives AD progression. Mice will be examined for alterations in memory, amyloidosis, tau-pathology, oxidative stress, synaptic and metabolic function. Preliminary data suggest that mCa2+ uptake overload impairs the clearance of misfolded proteins and dysfunctional mitochondria. Therefore, we will mechanistically examine the link between mCa2+ exchange and autophagic and mitophagic pathways. Optimally, the proposed studies will discover new therapeutic targets for AD and associated mitochondrial dysfunction and provide a training and research platform to promote the PIs independent research career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial calcium uptake in Alzheimer’s disease
Mitochondrial calcium uptake in Alzheimer's disease
  • 批准号:
    10239248
  • 项目类别:
  • 资助金额:
    $10.41万
  • 财政年份:
    2020
  • 负责人:
    Pooja Jadiya
  • 依托单位:
Mitochondrial calcium uptake in Alzheimer's disease. Admin Supplement
Mitochondrial calcium uptake in Alzheimer’s disease
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: